Studies have already shown that VEGF-A-165b has neuroprotective and neurotrophic effects in the CNS and PNS, but no effects on angiogenesis, while VEGF-B has already been shown to have neuroprotective effects in a Parkinson’s disease model [24,25,26]. This evidence concerns the gene VEGFB and Parkinson disease.